Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription

Articles published in PLoS Genet

Retrieve available abstracts of 19 articles:
HTML format

Single Articles

    April 2021
  1. TANG S, Buchman AS, De Jager PL, Bennett DA, et al
    Novel Variance-Component TWAS method for studying complex human diseases with applications to Alzheimer's dementia.
    PLoS Genet. 2021;17:e1009482.
    PubMed     Abstract available

  2. NACKENOFF AG, Hohman TJ, Neuner SM, Akers CS, et al
    PLD3 is a neuronal lysosomal phospholipase D associated with beta-amyloid plaques and cognitive function in Alzheimer's disease.
    PLoS Genet. 2021;17:e1009406.
    PubMed     Abstract available

    February 2021
  3. LIU N, Xu J, Liu H, Zhang S, et al
    Hippocampal transcriptome-wide association study and neurobiological pathway analysis for Alzheimer's disease.
    PLoS Genet. 2021;17:e1009363.
    PubMed     Abstract available

    January 2021
  4. MARQUILLY C, Busto GU, Leger BS, Boulanger A, et al
    Htt is a repressor of Abl activity required for APP-induced axonal growth.
    PLoS Genet. 2021;17:e1009287.
    PubMed     Abstract available

  5. BAIRD DA, Liu JZ, Zheng J, Sieberts SK, et al
    Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.
    PLoS Genet. 2021;17:e1009224.
    PubMed     Abstract available

    July 2020
  6. RATNAKUMAR A, Weinhold N, Mar JC, Riaz N, et al
    Protein-Protein interactions uncover candidate 'core genes' within omnigenic disease networks.
    PLoS Genet. 2020;16:e1008903.
    PubMed     Abstract available

    June 2020
  7. MILIND N, Preuss C, Haber A, Ananda G, et al
    Transcriptomic stratification of late-onset Alzheimer's cases reveals novel genetic modifiers of disease pathology.
    PLoS Genet. 2020;16:e1008775.
    PubMed     Abstract available

    February 2020
  8. RAMDHANI S, Navarro E, Udine E, Efthymiou AG, et al
    Tensor decomposition of stimulated monocyte and macrophage gene expression profiles identifies neurodegenerative disease-specific trans-eQTLs.
    PLoS Genet. 2020;16:e1008549.
    PubMed     Abstract available

    May 2019
  9. ONOS KD, Uyar A, Keezer KJ, Jackson HM, et al
    Enhancing face validity of mouse models of Alzheimer's disease with natural genetic variation.
    PLoS Genet. 2019;15:e1008155.
    PubMed     Abstract available

    December 2018
  10. RAJABLI F, Feliciano BE, Celis K, Hamilton-Nelson KL, et al
    Ancestral origin of ApoE epsilon4 Alzheimer disease risk in Puerto Rican and African American populations.
    PLoS Genet. 2018;14:e1007791.
    PubMed     Abstract available

    November 2018
  11. RATHORE N, Ramani SR, Pantua H, Payandeh J, et al
    Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer's disease.
    PLoS Genet. 2018;14:e1007427.
    PubMed     Abstract available

    April 2018
  12. LANCOUR D, Naj A, Mayeux R, Haines JL, et al
    One for all and all for One: Improving replication of genetic studies through network diffusion.
    PLoS Genet. 2018;14:e1007306.
    PubMed     Abstract available

    November 2017
  13. FERNANDEZ MV, Kim JH, Budde JP, Black K, et al
    Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.
    PLoS Genet. 2017;13:e1007045.
    PubMed     Abstract available

    August 2017
  14. ROCCHI A, Yamamoto S, Ting T, Fan Y, et al
    A Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer's disease.
    PLoS Genet. 2017;13:e1006962.
    PubMed     Abstract available

    July 2017
  15. LU Q, Powles RL, Abdallah S, Ou D, et al
    Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease.
    PLoS Genet. 2017;13:e1006933.
    PubMed     Abstract available

  16. KIM E, Sakata K, Liao FF
    Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation.
    PLoS Genet. 2017;13:e1006849.
    PubMed     Abstract available

    March 2017
  17. KERR F, Sofola-Adesakin O, Ivanov DK, Gatliff J, et al
    Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
    PLoS Genet. 2017;13:e1006593.
    PubMed     Abstract available

    November 2016

  18. Correction: Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease.
    PLoS Genet. 2016;12:e1006456.
    PubMed     Abstract available

    October 2016
  19. JAKOBSDOTTIR J, van der Lee SJ, Bis JC, Chouraki V, et al
    Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease.
    PLoS Genet. 2016;12:e1006327.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.